Correlation Between Adimmune Corp and SCI Pharmtech

Can any of the company-specific risk be diversified away by investing in both Adimmune Corp and SCI Pharmtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adimmune Corp and SCI Pharmtech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adimmune Corp and SCI Pharmtech, you can compare the effects of market volatilities on Adimmune Corp and SCI Pharmtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adimmune Corp with a short position of SCI Pharmtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adimmune Corp and SCI Pharmtech.

Diversification Opportunities for Adimmune Corp and SCI Pharmtech

-0.81

Correlation Coefficient

Adimmune Corp  SCI Pharmtech

Pay attention - limited upside

The 3 months correlation between Adimmune and SCI is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Adimmune Corp and SCI Pharmtech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCI Pharmtech and Adimmune Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adimmune Corp are associated (or correlated) with SCI Pharmtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCI Pharmtech has no effect on the direction of Adimmune Corp i.e., Adimmune Corp and SCI Pharmtech go up and down completely randomly.

Pair Corralation between Adimmune Corp and SCI Pharmtech

Assuming the 90 days trading horizon Adimmune Corp is expected to under-perform the SCI Pharmtech. In addition to that, Adimmune Corp is 1.19 times more volatile than SCI Pharmtech. It trades about -0.37 of its total potential returns per unit of risk. SCI Pharmtech is currently generating about 0.09 per unit of volatility. If you would invest  8,780  in SCI Pharmtech on September 14, 2024 and sell it today you would earn a total of  470.00  from holding SCI Pharmtech or generate 5.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Adimmune Corp  vs.  SCI Pharmtech

Adimmune Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Adimmune Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

SCI Pharmtech

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in SCI Pharmtech are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, SCI Pharmtech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Adimmune Corp and SCI Pharmtech

The main advantage of trading using opposite Adimmune Corp and SCI Pharmtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adimmune Corp position performs unexpectedly, SCI Pharmtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCI Pharmtech will offset losses from the drop in SCI Pharmtech's long position.

The idea behind Adimmune Corp and SCI Pharmtech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.